Set 20, 2016
Emma Walmsley becomes latest female CEO in FTSE 100
Emma Walmsley has become the newest female boss in the FTSE 100 after she was named successor to Sir Andrew Witty at British pharmaceutical giant GlaxoSmithKline.
Ms Walmsley, currently boss of GSK's Consumer Healthcare division, will take the reins from Sir Andrew when he retires on March 31, 2017. She will join the GSK board on January 1, the company said in a statement this morning.
The new boss will become the seventh female chief executive in the FTSE 100, after Moya Greene at Royal Mail, Alison Cooper at Imperial Brands, Alison Brittain at Whitbread, Liv Garfield at Severn Trent, Veronique Laury at Kingfisher and Carolyn McCall at EasyJet. However GSK's market cap is larger than any of these companies, making Ms Walmsley arguably the most powerful female boss in the index.
Ms Walmsley, who is 47 and has four children, has held her current role since 2015, when the Consumer Healthcare division was reshaped following a three-part transaction with rival firm Novartis.
She joined GSK in 2010 from L'Oreal where, over the course of her 17-year career, she held a variety of marketing and general management roles in the UK, Europe, the US and China.
By Jon Yeomans
20 September 2016